Activation of p38 Mitogen-Activated protein kinase is required for death receptor-independent caspase-8 activation and cell death in response to sphingosine

Molecular Cancer Research

Volumn 7, Issue 3, 2009, Pages 361-370

  Yoon, Chang Hwan ^a   Kim, Min Jung ^a   Park, Moon Taek ^a   Byun, Joo Yun ^a   Choi, Young Hyun ^b   Yoo, Hwan Soo ^c   Lee, Yong Moon ^c   Hyun, Jin Won ^d   Lee, Su Jae ^a  

^a Hanyang University   (South Korea)

^b Department of Oriental Medicine   (South Korea)

^c Chungbuk National University   (South Korea)

^d Jeju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; DEATH RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOPROTEIN PHOSPHATASE 2A; SMALL INTERFERING RNA; SPHINGOLIPID; SPHINGOSINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; CASPASE 8; CELL DEATH; CELL SURVIVAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JURKAT CELLS; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN PHOSPHATASE 2; RECEPTORS, DEATH DOMAIN; RNA, SMALL INTERFERING; SPHINGOSINE;

EID: 62549092657     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0069     Document Type: Review

References (33)

1. Maceyka M, Payne SG, Milstien S, Spiegel S. Sphingosine kinase, sphingosine-1 -phosphate, and apoptosis. Biochim Biophys Acta 2002:1585:193-201.
2. Pena LA, Fuks Z, Kolesnick R. Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 1997;53:615-21.
3. Cuvillier O. Sphingosine in apoptosis signaling. Biochim Biophys Acta 2002;1585:153-62.
4. Cuvillier O, Rosenthal DS, Smulson ME, Spiegel S. Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes. Nature 1996;381:800-3.
5. Jarvis WD, Fornari FA, Jr., Auer KL, et al. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol Pharmacol 1997;52:935-47.
6. Jarvis WD, Fornari FA, Jr., Tombes RM, et al. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-β-D-arabinofuranosylcyiosine-induced apoptosis by interruption of protein kinase C signaling. Mol Pharmacol 1998;54:844-56.
7. Sakakura C, Sweeney EA, Shirahama T, et al. Selectivity of sphingosine-induced apoptosis. Lack of activity of DL-erythyro- dihydrosphingosine. Biochem Biophys Res Commun 1998;246:827-30.
8. Li T. Dai W, Lu L. Ultraviolet-induced junD activation and apoptosis in myeloblasts leukemia ML-1 cells. J Biol Chem 2002;277:32668-76.
9. Bowen C, Birrer M, Gelmann EP. Retinoblastoma protein-mediated apoptosis after γ-irradiation. J Biol Chem 2002;277:44969-79.
10. Ouwens DM, Gomes de Mesquita DS, Dekker J, Maassen. Hyperosmotic stress activates the insulin receptor in CHO cells. Biochim Biophys Acta 2001;1540:97-106.
11. Benhar M, Dalyot I, Engelberg D, Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 2001;21:6913-26.
12. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME, Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-31.
13. Shelton JG, Steelman LS, Lee JT, et al. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells. Oncogene 2003;22:2478 - 92.
14. Berra E, Municio MM, Sanz L, frutos S, Diaz-Meco MT, Moscat J. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade. Mol Cell Biol 1997;17:4346-54.
15. Alessi DR, Gomez N, Moorhead G, Lewis T, Keyse SM, Cohen P. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr Biol 1995;5:283-95.
16. Anderson NG, Mailer JL, Tonks NK, Sturgill TW. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 1990;343:651-3.
17. Garcia L, Garcia F, Llorens F, Unzeta M, Itarte E, Gomez N. PP1/PP2A phosphatases inhibitors okadaic acid and calyculin A block ERK5 activation by growth factors and oxidative stress. FEBS Lett 2002;523:90-4.
18. Gomez N, Cohen P. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 1991;353:170-3.
19. Millward TA, Zolnierowicz S, Flemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999;24:186-91.
20. Zhou B, Wang ZX, Zhao Y, Brautigan DL, Zhang ZY. The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases. J Biol Chem 2002;277:31818-25.
21. Howe AK, Gaillard S, Bennett JS, Rundell K. Cell cycle progression in monkey cells expressing simian virus 40 small t antigen from adenovirus vectors. J Virol 1998;72:9637 - 44.
22. Mitsuhashi S, Shima H, Tanuma N, et al. Usage of tautomycetin, a novel inhibitor of protein phosphatase 1 (PP1), reveals that PP1 is a positive regulator of Raf-1 in vivo. J Biol Chem 2003;278:82-8.
23. Westermarck J, Li SP, Kallunki T, Han J, Kahari VM. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol Cell Biol 2001;21:2373-83.
24. Avdi NJ, Malcolm KC, Nick JA, Worthen GS. A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils. J Biol Chem 2002;277:40687-96.
25. Kim MR. Lee JY, Park MT. et al. Ionizing radiation can overcome resistance to TRAIL in TRAIL-resistant cancer cells. FEBS Lett 2001;505:179-84.
26. Min JK, Yoo HS, Lee EY, Lee WJ. Lee TM. Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o -phthalalde- hyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Anal Biochem 2002;303:167-75.
27. Green DR. Apoptosis. Death deceiver. Nature 1998;396:629-30.
28. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibìtíon of distinct caspases. EMBO J 1998;17:2215-23.
29. Cheng A, Chan SL, Milhavet O, Wang S, Mattson MP. p38 MAP kinase mediates nitric oxide-induced apoptosis of neural progenitor cells. J Biol Chem 2001;276:43320-7.
30. 2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils. Clin Exp Immunol 2000;122:20-7.
31. Galan A, Garcia-Bermejo ML, Troyano A, et al. Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocyte cells. J Biol Chem 2000;275:11418-24.
32. Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 2000;275:39435-43.
33. Soderstrom TS, Poukkula M, Holmstrom TH, Heiskanen KM, Eriksson JE. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8. J Immunol 2002;169:2851-60.